Longitudinal Multimodal Neuroimaging Studies in Patients With First Episode Psychosis
NCT ID: NCT01688765
Last Updated: 2022-09-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
187 participants
OBSERVATIONAL
2012-10-17
2022-09-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Identification of Patients Presenting a First Psychotic Episode, Non Answering to First Line Support Strategies
NCT02670447
Clinical and Biological Characteristics of Psychotic Depression
NCT00576095
Cerebellar Modulation of Cognition in Psychosis
NCT06107764
Remote State Representation in Early Psychosis
NCT05538832
Brain Imaging in Early Psychosis
NCT03932188
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study design is case-control, there are no interventions.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
First Episode Psychosis Patients
Individuals experiencing a first episode of psychosis
Observational
Healthy Controls
Psychiatrically healthy individuals
Observational
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Observational
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Healthy controls with no psychiatric disorder history
Exclusion Criteria
* Ages \<18 or \>45
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mclean Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dost Ongur
M.D, PhD, Clinical Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dost Ongur, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Mclean Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
McLean Hospital
Belmont, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2012P001796
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.